216 related articles for article (PubMed ID: 15532725)
1. AT2 receptor and apoptosis during AT1 receptor blockade in reperfused myocardial infarction in the rat.
Jugdutt BI; Menon V
Mol Cell Biochem; 2004 Jul; 262(1-2):203-14. PubMed ID: 15532725
[TBL] [Abstract][Full Text] [Related]
2. AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction.
Jugdutt BI; Menon V
Mol Cell Biochem; 2004 May; 260(1-2):111-8. PubMed ID: 15228092
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of angiotensin II type 2 receptor and limitation of myocardial stunning by angiotensin II type 1 receptor blockers during reperfused myocardial infarction in the rat.
Jugdutt BI; Menon V
J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):217-26. PubMed ID: 14506547
[TBL] [Abstract][Full Text] [Related]
4. Increased AT2R protein expression but not increased apoptosis during cardioprotection induced by AT1R blockade.
Moudgil R; Musat-Marcu S; Xu Y; Kumar D; Jugdutt BI
Can J Cardiol; 2002 Aug; 18(8):873-83. PubMed ID: 12215750
[TBL] [Abstract][Full Text] [Related]
5. Valsartan-induced cardioprotection involves angiotensin II type 2 receptor upregulation in dog and rat models of in vivo reperfused myocardial infarction.
Jugdutt BI; Menon V
J Card Fail; 2004 Feb; 10(1):74-82. PubMed ID: 14966778
[TBL] [Abstract][Full Text] [Related]
6. Increased AT(2)R protein expression but not increased apoptosis during cardioprotection induced by AT(1)R blockade.
Moudgil R; Musat-Marcu S; Xu Y; Kumar D; Jugdutt BI
Can J Cardiol; 2002 Oct; 18(10):1107-16. PubMed ID: 12420045
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotection induced by AT1R blockade after reperfused myocardial infarction: association with regional increase in AT2R, IP3R and PKCepsilon proteins and cGMP.
Jugdutt BI; Xu Y; Balghith M; Moudgil R; Menon V
J Cardiovasc Pharmacol Ther; 2000 Oct; 5(4):301-11. PubMed ID: 11150400
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of increased secretory leukocyte protease inhibitor, matricellular proteins and angiotensin II and left ventricular remodeling by candesartan and omapatrilat during healing after reperfused myocardial infarction.
Palaniyappan A; Uwiera RR; Idikio H; Menon V; Jugdutt C; Jugdutt BI
Mol Cell Biochem; 2013 Apr; 376(1-2):175-88. PubMed ID: 23361363
[TBL] [Abstract][Full Text] [Related]
9. Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs.
Jalowy A; Schulz R; Dörge H; Behrends M; Heusch G
J Am Coll Cardiol; 1998 Nov; 32(6):1787-96. PubMed ID: 9822110
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats.
Walters PE; Gaspari TA; Widdop RE
Hypertension; 2005 May; 45(5):960-6. PubMed ID: 15767466
[TBL] [Abstract][Full Text] [Related]
11. AT1 receptor blockade alters metabolic, functional and structural proteins after reperfused myocardial infarction: detection using proteomics.
Jugdutt BI; Sawicki G
Mol Cell Biochem; 2004 Aug; 263(1-2):179-88. PubMed ID: 15524179
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin receptor blockade and angiotensin-converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dysfunction during healing after reperfused ST-elevation myocardial infarction.
Jugdutt BI; Idikio H; Uwiera RR
Mol Cell Biochem; 2007 Sep; 303(1-2):27-38. PubMed ID: 17426929
[TBL] [Abstract][Full Text] [Related]
13. AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling.
Oishi Y; Ozono R; Yoshizumi M; Akishita M; Horiuchi M; Oshima T
Life Sci; 2006 Dec; 80(1):82-8. PubMed ID: 17023005
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion model.
Dai W; Hale SL; Kay GL; Jyrala AJ; Kloner RA
Cardiovasc Ther; 2010; 28(1):30-7. PubMed ID: 20074257
[TBL] [Abstract][Full Text] [Related]
15. Valsartan-induced cardioprotection involves angiotensin II type 2 receptor upregulation in isolated ischaemia and reperfused rat hearts.
Li KY; Zhang YJ
Acta Cardiol; 2015 Feb; 70(1):67-72. PubMed ID: 26137805
[TBL] [Abstract][Full Text] [Related]
16. AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade.
Widdop RE; Matrougui K; Levy BI; Henrion D
Hypertension; 2002 Oct; 40(4):516-20. PubMed ID: 12364356
[TBL] [Abstract][Full Text] [Related]
17. Role of angiotensin II AT1 and AT2 subtype receptors in the regulation of atrial natriuretic peptide expression in salt-restricted rats.
Gigante B; Piras O; Savoia C; De Paolis P; Rubattu S; Panina G; Volpe M
Basic Res Cardiol; 2000 Feb; 95(1):64-9. PubMed ID: 10752547
[TBL] [Abstract][Full Text] [Related]
18. AT2 receptors contribute to acute blood pressure-lowering and vasodilator effects of AT1 receptor antagonism in conscious normotensive but not hypertensive rats.
Duke LM; Evans RG; Widdop RE
Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2289-97. PubMed ID: 15615839
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors.
Faure S; Bureau A; Oudart N; Javellaud J; Fournier A; Achard JM
J Hypertens; 2008 Oct; 26(10):2008-15. PubMed ID: 18806625
[TBL] [Abstract][Full Text] [Related]
20. Enhanced regional AT(2)-receptor and PKC(epsilon) expression during cardioprotection induced by AT(1)-receptor blockade after reperfused myocardial infarction.
Jugdutt BI; Balghith M
J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):134-40. PubMed ID: 11881113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
